Sesqui-and oxy-mustards pose a significant threat to military forces and civilians because they are potent vesicants. We have developed an isotope-dUution high-performance liquid chromatography-atmospheric pressure chemical ionizationtandem mass spectrometry method utilizing negative ion multiple reaction monitoring for the analysis of sesqui-mustard metabolites bis(2-hydroxyethylthio)alkanes (n = 1-5) and oxy-mustard metabolite bis(2-hydroxyethylthioethyl)ether in human urine. Relative standard deviations were < 10% and the reportable limits of detection were I ng/ml in 0.5 mL of urine. We applied this method to 100 samples collected from individuals with no known exposure to sesqui-or oxy-mustards, and no urines showed detectable levels of any of the analytes, suggesting that these metabolites may be used for monitoring exposure to sesqui-and oxy-mustards.
Introduction
Chemical compounds with vesicant properties pose a significant threat to military forces and civilians. The use of a vesicant or other chemical warfare agent (CWA) against civilian populations is expected to result in a significant number of "worried well". An influx of the "worried well" would burden a medical system attempting to respond to patients presenting genuine symptoms of chemical exposure. Beyond the initial emergency response, a secondary effect associated with the debilitating effects of vesicants is that additional resources would be required for long-term care. Medical follow-up of victims exposed to sulfur mustard (HD) during the Iraq-Iran war (1) has suggested that, in addition to the obvious acute consequences of exposure, long-term health effects may occur in patients who recover from the initial acute skin lesions and accompanying maladies. Thus, it is important to distinguish between the "worried well" and patients who may have low-level or sub-acute exposure. Long-term treatment may also be important as we learn more about the debilitating effects of vesicants.
In addition to the more commonly known vesicant HD, sesqui-and oxy-mustard analogues of HD are listed on Schedule 1 of the Chemical Weapons Convention and present a public health threat (2) . Two of these analogues, known as Agents Q and T, are major components in the weapons-grade munitions, HQ and HT, respectively (3) . HD metabolism has been studied extensively (4) (5) (6) (7) (8) , and thiodiglycol sulfoxide (TDGSOX) has been found to be a major urinary excretion product (6) , but sesqui-and oxy-mustard studies have focused on toxic effects and lethal dosages for various species (9, 10) rather than on elucidation of urinary metabolites. Sesqui-and oxy-mustards degrade to diols and sulfoxides (11) through hydrolysis (12, 13) and oxidation processes analogous to those that convert HD to thiodiglycol (TDG) and TDGSOX during environmental degradation. Likewise, it is inferred that sesquiand oxy-mustards in biological systems metabolize to dioland sulfoxide-analogues of TDG and TDGSOX. Such biomarkers of exposure can be used initially to identify the CWA used and to differentiate between those with different levels of exposure and the "worried-well" through the analysis of biological fluids.
Although the literature contains numerous reports on the analysis of TDG and TDGSOX (14) (15) (16) (17) (18) , there are only a few reports (12, (19) (20) (21) (22) on the analysis of sesqui-and oxy-mustard degradation products in environmental matrices, and no reports were found on analysis in biological matrices. Multiple degradation products, including the ones shown in Figure 1 , were identified among the degradation products of munitions grade HQ and HT both by gas chromatography (GC) (12) high-performance liquid chromatography coupled to mass spectrometry (HPLC-MS) (19) . Subsequently, D'Agostino et al. (19) identified these compounds in aqueous samples collected at a former mustard destruction site and in soil extracts from a former mustard storage area (20, 21) . The previously mentioned methods are very powerful for the analysis of mustard degradation products in environmental matrices. To address the need for a sensitive and specific multimetabolite method for the analysis of sesqui-and oxy-mustard metabolites associated with exposure to sulfur mustard vesicant type CWA, we expanded our previous research (23) on superoxide anions in atmospheric pressure chemical ionization tandem MS (APCI-MS-MS) to urinary metabolites. The focus of this work was the development and validation of an HPLC isotope-dilution negative-ion APCI-MS-MS method for the analysis of sesqui-and oxy-mustard hydrolysis products. Additionally, we applied this method to samples collected from individuals with no known exposure to sesqui-and oxy-mustards to explore possible interferences with the method and to serve as a limited reference range study.
Experimental

Materials
The sesqui-and oxy-mustard metabolites (bis [2- Reference range samples were purchased from Tennessee Blood Services (Memphis, TN). The urine samples were collected from anonymous donors, and no demographic information was obtained. Therefore, these samples were determined to be exempt from human subjects review. All samples were stored at -70~ until the time of analysis.
Preparation of standards and quality control (QC) materials
Native standards and QC materials. Standards and QC materials were prepared from a urine pool collected from multiple anonymous donors via a protocol approved by the CDC's Institutional Review Board. A stainless steel pressurized dispenser was used to filter the urine through a 0.2-1Jm filter. The filtered urine was homogenized overnight and divided into multiple aliquots. The 1000 t~g/mL individual primary standards were combined and diluted with acetonitrile to prepare two multianalyte working stock solutions at 10 and 1 lJg/mL. Aliquots of the pooled urine were enriched with the appropriate multianalyte working stock to create seven calibration standards (1, 2, 3, 10, 20, 50, and 100 ng/mL) and QCs of 5.0 and 40 ng/mL. The remaining aliquot was used as the method blank. The enriched urine standards and blank were dispensed in 0.5-mL aliquots into 15-mL screw-cap culture tubes, stored at -20~ and analyzed to establish calibration plots for quantification. The long-term storage temperature for neat compounds, stock solutions of native and labeled standards, enriched urine samples, and QC materials was -70~
Labeled standards. Individual 13C4-1abeled metabolite stocks were made by weighing 25 mg of the labeled metabolite into 2 mL of acetonitrile, except for BHETPn-13C4 . The BHETPn-13C4-1abeled metabolite stock was prepared by weighing 10 mg into 2 mL of acetonitrile. Aliquots from each labeled stock were combined and diluted with acetonitrile to obtain the multianalyte labeled spiking solution used as the internal standard. The final concentration of each labeled metabolite was 250 ng/mL, except for BHETPn-13C 4 (500 ng/mL). Labeled internal standard solutions were stored at -20~ during method development.
Sample preparation. A urine sample (0.5 mL) was placed into a 15-mL screw-cap culture tube and spiked with 20 IJL of the multianalyte labeled internal standard for a final concentration of 10 ng/mL for all labeled metabolites except BHETPn-13C 4 (20 ng/mL). One milliliter of acidified titanium trichloride was added to each sample as a reducing agent. The samples were capped, vortex mixed, and placed in a covered water bath at 50~ for 45 min. After incubation, the samples were removed and allowed to cool to room temperature before addition of 2 mL of 1N potassium hydroxide. Samples were vortex mixed to mix and dissolve any solids.
The first step in the two-step cleanup was performed via immobilized liquid-liquid extraction using 3-mL Chem Elut unbuffered cartridges and a mixture of 60:40 dichloromethane/ acetonitrile as the elution solvent. The partially neutralized, re-duced samples were applied to the Chem Elut cartridges and immediately extracted using 16 mL of 60:40 dichloromethane/ acetonitrile. Eluents were collected in 15-mL conical centrifuge tubes and were placed into a TurboVap | evaporator (Caliper Life Science, Hopkinton, MA) at 50~ with an initial nitrogen pressure of 2 psi. The nitrogen pressure was increased to 10 psi when the solvent volume in the tubes was reduced by half. Additional reagent-grade acetonitrile (400 ~L) was added to remove residual water. Sample volumes were reduced to approximately 0.5 mL.
The second cleanup step consisted of removal of highly polar contaminants via solid-phase extraction (SPE). The 0.5 mL sample extract and 1 mL of acetonitrile used to aid analytical transfer of the metabolites from the evaporation tube were transferred to a 5-mL syringe barrel fitted with a classic Florisil Sep-Pak cartridge. Acetonitrile was added for a final volume of 5 mL. The syringe plunger was inserted to expel the eluent through the SPE cartridge, to the filter syringe, and into a 15-mL conical tube. Samples were placed into the evaporator at 50~ under 10 psi nitrogen pressure to dry. Acetonitrile (300 IJL) was added to facilitate the final drying process. Samples were reconstituted in 50 IJL of HPLC-grade water, vortex mixed, and transferred to 250-~L conical polypropylene autosampler vials for subsequent analysis by HPLC-APCI-MS-MS.
Chromatography and MS
Chromatographic conditions. The HPLC system was an Agilent 1100 LC system consisting of a binary pump, autosampier, column heater, and vacuum degasser (Agilent Technologies, Wilmington, DE). The system was optimized for low flow rates by removing the mixing chamber to reduce dead volume and by utilizing the autosampler valve-switching option in the software to reduce the solvent path. These modifications reduced the time required for the gradient to reach the column. A gradient separation was achieved at 45~ on a Hypersil Gold-aQ | 150 x 2.1-mm column with 3.0-~m particles (ThermoFisher Scientific, Waltham, MA). The chromatography solvents were water (A) and a mixture of (95:5) acetonitrile/isopropyl alcohol (B). The chromatographic run began with a 4 min equilibration, using 95% A and 5% B at 300 ~L/min. Gradient elution of all analytes was attained between 4.5 and 12.5 rain with increased organic phase to 35% B at 300 ~L/min. The flow rate and organic phase composition were increased as follows: at 15 min, 65% B at 400 IJL/min, at 18.5 min, 95% B at 500 ~L/min. The final flow rate was increased to 750 lJL/min and held for 10 min to ensure that highly retained constituents would be cleaned from the column. Sample size was a 20-~L injection.
MS conditions. HPLC-APCI-MS-MS was performed on an API 4000 triple-quadrupole MS (Applied BioSystems, Foster City, CA) interfaced to the aforementioned HPLC system. The APCI source was operated in negative ion mode at 5 IJA and 200~ The nebulizer gas (air) and curtain gas (nitrogen) pressures were set to 80 and 25 psi, respectively. Collision-induced dissociation was performed with the collision gas (nitrogen) set at 6 arbitrary units for an average pressure reading of 2.2 • 0.1 x 10 -5 Torr on the vacuum gauge. Individual metabolites were
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monitoring (MRM) parameters were optimized for the analytes monitored within the timed segment. Mass resolution was set to high (0.5 • 0.1 amu at half-height) for Q1 and to unit (0.7 • 0.1 amu at half-height) for Q3.
Data processing
Data was automatically acquired using Analyst 1.4.1 software and was processed using the IntelliQuan algorithm for quantification (Applied BioSystems). Extracted ion chromatograms were visually inspected for correct peak selection and baseline determination. If necessary, manual reintegration was performed. To detect possible isobaric interferences in unknown samples, ion ratios (quantitation ion peak area / confirmation ion peak area) were calculated for standards within the same analytical run (Access, Microsoft, Redmond, WA). For reference range, QC samples, and other unknown samples, ion ratios within + 20% of the calculated ion ratios for the standards were accepted, but samples lacking the confirmation ions or having ratios outside these limits were rejected. Westgard multi-rule criteria were used to evaluate QC materials via quality control charts. Violation of the Westgard rules for any QC rendered the analysis "out of control". Statistical analyses were performed using SAS statistical software (SAS Institute, Cary, NC).
Quantification
All samples, blanks, standards, and QC materials were processed identically. Seven multianalyte standard concentrations (i.e., nominally 1.0, 2.0, 3.0, 10, 20, 50, 100 ng/mL in human urine) were used to construct calibration curves. Quantification of the metabolites in the unknown samples was based on the x-y relationship between the response factors (RF: observed ratio of native peak area to labeled peak area) versus concentration of the native weighted by 1/x (the reciprocal of the standard concentration ratio). Such calibration curves were used to quantify bench QCs, method blanks, and unknown samples for method validation. A representative calibration curve for BHETM with an expanded plot of the four low standards is shown in Figure 2 .
Results and Discussion
The scientific literature for sulfur mustards contains numerous references for TDG, a diol (hydrolysis product), and urinary metabolite of HD (4) (5) (6) (7) (8) . Additionally, the sesqui-and oxy-mustards (11-13) degrade in the environment via hydrolysis to diols analogous to TDG. We, therefore, inferred that the sesqui-and oxy-mustard hydrolysis products would also be urinary metabolites. However, there is no information in the literature for clinical sample analysis of the sesqui-and oxymustard hydrolysis products. Therefore, we developed an analytical method to quantify five sesqui-and oxy-mustard (T) hydrolysis metabolites in urine and plan an animal study to confirm the metabolites. The method development was corn-prised of several stages that included the development of the sample preparation procedure and optimization of the chromatographic and MS conditions for each metabolite.
Sample preparation
The use of acidic titanium trichloride, a widely used reducing agent, has been reported by Black et al. (24) and Boyer et al. (25) for the reduction of oxidized sulfur mustard metabolites. Our reduction was adapted from these prior researchers with two modifications: 1. a lower temperature and shorter incubation time was needed to minimize the thermal degradation of the sesqui-and oxy-mustards and 2. a low normality potassium hydroxide (KOH) solution was used to prevent the formation of solids that reduced recovery efficiencies. First, the lower temperature improved recovery of all metabolites tested except the methyl oxy-mustard hydrolysis product, BHETME. No reducing conditions were found that prevented BHETME from undergoing a total conversion to BHETM. Similar behavior was reported for mass spectral analysis of BHETME by GC-MS-MS (26) and HPLC-APCI-MS-MS (23) . Second, the addition of 2 mL of 1N KOH produced little heat-of-neutral-'t ization and no solids resulting in high recovery (> 85%). However, to attain our target detection limit, further cleanup was required. Black et al. (24) reported on the extraction of TDG via a combination of immobilized liquid-liquid extraction and florisil SPE; therefore, we chose florisil for additional cleanup. Florisil extracts were free from interferences and resulted in reportable limits of I ng/mL. Sample preparation took approximately 2.5 h for 40 samples with < 30 min analytical run times.
BHETE BHETEE
Recovery efficiencies for the metabolites from the spiked urine were determined from triplicate analysis of standards at two levels, 5 and 20 ng/mL. The recovery was calculated as the percentage of RFR/RFc, where RFn and RFc are the response factors obtained from spiking half the samples with isotopically labeled analogues before the TiC13 reduction procedure and half at final reconstitution in water for analysis. Recovery efficiencies varied from 27% to 47% for 5 ng/mL and 43% to 55% for 20 ng/mL, with BHETM and BHETE having lower recovery efficiencies. Because isolation of low molecular weight polar compounds from polar matrices is challenging, the reported recoveries represent an acceptable compromise between high recovery, simplicity of cleanup steps, and reduction of interferences for the multi-analyte method. The inherent variation of the extraction process and the concept of diminishing recoveries with decreasing concentration can account for the variation seen in recovery efficiencies at different concentrations. Isotope dilution analysis corrects for analyte recoveries because the chemical behavior of 13C-labeled isotopes is almost identical to the native compounds; thus, the recoveries do not affect the accuracy of the quantification.
Chromatography and MS
The sesqui-mustards are a relatively polar, homologous series and are thus easily separated on a C18 column. The shorter chain, lower molecular weight sesqui-mustard metabolites required an initial mobile phase of high aqueous content to achieve acceptable retention and separation from matrix interferences. The Hypersil Gold-aQ | polar end-capped column with side alkyl chains gave the best peak shape and separation of the columns tested. The oxy-mustard, BHETEE, eluted between the two sesqui-mustards, BHETE and BHETPr. A representative multi-segment chromatogram (Figure 3) shows a typical prepared urine blank (top) and a urine sample spiked with 20 ng/mL of the native sesqui-and oxy-mustard standard mixture. Gradient elution of all analytes was attained within 12.5 min by increasing %B from 5% to 35%. Formic acid inhibited the formation of the superoxide adduct, (M + O2)-, and therefore could not be used to improve chromatographic peak shape (23) . However, the addition of isopropyl alcohol to the organic phase to facilitate the removal of late eluting components also led to improved peak shape and the reduction of baseline noise.
Chromatographic resolution is typically unnecessary for analytes that are resolved by their mass-to-charge ratio. However, when monitoring multiple ions from multiple analytes, adequate chromatographic separation not only minimizes the competition for ionization from matrix components, but also permits the mass acquisition to be subdivided into discrete time segments in which only the analytes that elute within the selected time frame are measured. Use of timed segments limits the number of ions acquired, increases signal integration time, and reduces extraneous baseline noise resulting in increased sensitivities and optimized ion statistics across each peak. Chromatographic separation was sufficient for BHETM, BHETE, BHETB, and BHETPn to be acquired in separate time segments (Table II) . BHETEE and BHETPr were chromatographically resolved (Rs < 1.2), but did not have adequate separation to be acquired in separate time segments; therefore, both were acquired in segment 3 with no detrimental effects on quantification.
During method development, several precursor/product ion transitions of (M + 02)-were monitored. Some of the precursor/ product ion transitions monitored for aqueous standards in our previous report (23) , however, were unsuitable for measurement of prepared urine standards because of unresolved matrix interferences. Therefore, the selected quantitation and confirmation ions for each native/labeled metabolite pair represent the best choice with regard to the desired method limit of detection and freedom from interferences (Table I) .
Method validation
Two QC levels (5 and 40 ng/mL) were characterized by 20 analyses conducted over a 2-month period to define the means, the 95th and 99th confidence intervals, and the precision and accuracy of the analysis for each metabolite. A representative QC chart for BHETM at 5 ng/mL is given in Figure 4 . Dayto-day precision was evaluated by calculating the percent relative standard deviation (%RSD) of the calculated concentrations of the low and high QC materials. %RSD was between 3.8% and 7.9% for all metabolites, reflecting good precision over the analysis period for both low and high QC materials. Accuracy was evaluated by comparing the calculated concentrations with the expected concentrations of QC materials. The accuracy on the low QC (5 ppb) ranged from 100% to 105% and on the high QC (40 ppb) from 106% to 107%. The sesqui-and oxy-mustard metabolite method produced weighted linear calibration curves with R 2 ~ 0.99 and relative standard errors of < 10% for each analyte quantitation and confirmation ions over two orders of magnitude (1 to 100 ng/mL) (Table  II) . Furthermore, confirmation ions were quantifiable for each analyte to the lowest standard (1 ng/mL) except for BHETM at 2 ng/mL. Data for the individual metabolites were averaged for n = 20 and presented in Table II . QC materials reanalyzed after the initial characterization showed that calibration and QC materials remain stable at -20~ for at least 1 year; however, in our laboratory, -70~ is preferred for long-term storage.
The standard deviation of the blank (So) for each analyte was estimated from 17 standard runs during a two-month period as the y-intercept of the linear regression of the plot of the expected concentrations versus the standard deviations of three low standards (27) . The method limits of detection (LOD) given in Table II were calculated as 3S0 and are below the lowest calibrator for all the metabolites. Standards containing 0.5 ng/mL were analyzed and quantitation peaks were detected for most analytes. However, no confirmation ions were detected; hence, the lowest reportable limit for the method was set at I ng/mL, the lowest calibrator.
Reference range determinations
The extent of exposure to a CWA must be weighed against background levels that may be present or urinary components that may interfere with the measurement of the metabolites of interest. To determine possible background levels of the sesquiand oxy-mustard metabolites in the urine of a population with no known exposure and to test for possible method interferences that may lead to "false positives", we analyzed 100 randomly collected human urine samples from Tennessee Blood Services. No sesqui-or oxy-mustard metabolites were detected in the samples analyzed.
Conclusions
Complex biological matrices such as human urine pose challenges in sample preparation, often requiring multiple steps and sample concentration to obtain the ultra low ng/mL detection limits required for the biological monitoring of possible exposure to chemical agents. Sesqui-and oxy-mustard metabolites are important biomarkers for sulfur mustard vesicants listed on the Chemical Warfare Convention Schedule of Chemicals. We have developed an isotope-dilution HPLC-APCI-MS-MS method for the quantification of sesquiand oxy-mustard metabolites at the low nanogram-permilliliter levels required for the analysis of biomarkers in urine. The method affords us not only screening capabilities but quantification capabilities for five sesqui-and one oxy-mustard metabolites to low nanogram-per-milliliter levels with confirmation for each analyte. Additionally, we have applied this method to the analysis of human urine samples from an unexposed population to determine the "normal" concentrations of sesqui-or oxy-mustard metabolites in the general population. The absence of background levels in the unknown samples indicates that the metabolites may be used to provide evidence of exposure to these mustard compounds. Thus, we have shown that ad isotope dilution HPLC-APCI-MS-MS method is viable for the quantification of sesqui-and oxy-mustard metabolites at the low nanogram-per-milliliter levels required for biomonitoring. As time permits, we plan to automate the SPE procedure and shorten the instrument method to better support our emergency response activities.
